Helping eligible patients experiencing financial hardship
Forest Laboratories, LLC is pleased to offer the Aptalis Patient Assistance Program (PAP)*, which was created to help eligible patients
receive financial assistance for the medications CANASA®, PYLERA®, RECTIV®,
ULTRESA®, VIOKACE®, and ZENPEP®.
This program is designed for patients experiencing financial hardship who earn too much to qualify for government-funded programs,
but don’t have third-party insurance coverage. The Aptalis PAP allows these patients greater access to the Forest Laboratories medication
prescribed by their doctor.
Covered medications include:
CANASA®, PYLERA®, RECTIV®, and VIOKACE®
are registered trademarks of Actavis, Inc. or its affiliates.
ULTRESA® and ZENPEP® and their designs are registered trademarks of Actavis, Inc. or its affiliates.